Acta Pharmacologica Sinica 2006-04-01

CJZ3, a lomerizine derivative, modulates P-glycoprotein function in rat brain microvessel endothelial cells.

Bian-Sheng Ji, Ling He, Xiao-Qu Li, Guo-Qing Liu

Index: Acta Pharmacol. Sin. 27(4) , 414-8, (2006)

Full Text: HTML

Abstract

To investigate the modulatory effect of CJZ3, a lomerizine derivative, on P-glycoprotein (P-gp) function in rat brain microvessel endothelial cells (RBMEC).RBMEC were isolated and cultured in Dulbecco modified Eagle medium/F12 (1:1) medium, and the amount of intracellular rhodamine 123 (Rh123) was determined using a fluorescence spectrophotometer to evaluate the modulatory effect of CJZ3 on P-gp function.The accumulation of Rh123 was potentiated in a concentration-dependent manner after incubation with CJZ3 for RBMEC, but not for human umbilical vein endothelial cells (HUVEC). CJZ3 caused the accumulation of intracellular Rh123 in a time-dependent manner and significantly decreased the efflux of Rh123 from the cells. The inhibitory effect of CJZ3 on P-gp function was reversible and remained for 120 min after CJZ3 (2.5 micromol/L) was removed from the medium.CJZ3 has a potent in vitro effect on the inhibition of P-gp function.


Related Compounds

Related Articles:

A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.

2015-06-03

[Sci. Transl. Med. 7 , 290ra89, (2015)]

Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity.

2011-12-01

[Mol. Cell Biochem. 358(1-2) , 1-11, (2011)]

Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in guinea-pig whole blood.

2008-09-01

[J. Pharmacol. Sci. 108(1) , 89-94, (2008)]

A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat.

2006-03-01

[Curr. Eye Res. 31(3) , 273-83, (2006)]

Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine.

2001-05-01

[Biol. Pharm. Bull. 24(5) , 555-7, (2001)]

More Articles...